| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 43.592 | 38.506 | 24.839 | 20.944 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 43.593 | 38.509 | 24.842 | 20.946 | 2 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 24.477 | 25.754 | 23.381 | 19.802 | 565 | 57 | 67 | 56 | 78 | 0 |
| Gross Profit/Loss - EUR | 19.116 | 12.756 | 1.461 | 1.144 | -563 | -57 | -67 | -56 | -78 | 0 |
| Net Profit/Loss - EUR | 17.808 | 12.109 | 1.212 | 913 | -563 | -57 | -67 | -56 | -78 | 0 |
| Employees | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 35.110 | 29.630 | 19.748 | 18.329 | 11.827 | 11.670 | 9.478 | 9.451 | 8.394 | 8.347 |
| Inventories | 0 | 0 | 0 | 191 | 187 | 184 | 180 | 180 | 180 | 179 |
| Receivables | 13.054 | 15.603 | 10.974 | 10.023 | 9.509 | 9.053 | 8.634 | 8.368 | 7.979 | 7.935 |
| Cash | 22.057 | 14.028 | 8.774 | 8.115 | 2.131 | 2.433 | 665 | 902 | 235 | 234 |
| Shareholders Funds | 17.835 | 12.135 | 1.238 | 938 | -539 | -586 | -640 | -698 | -774 | -770 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 17.276 | 17.496 | 18.510 | 17.391 | 12.366 | 12.255 | 10.118 | 10.149 | 9.168 | 9.116 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8219 - 8219" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Medimed S.r.l.